Overview
Our fellows have access to a varied group of potential mentors for fellows, which include world-renowned scientists in varied areas of gynecologic oncology research. Once matched into the program, our division will assign the fellow to a research project and mentor.
Each of the mentors has supervised many previous graduate students and post-doctoral fellows.
Fellows are expected to participate in departmental seminars, laboratory meetings and other educational experiences (research retreats, etc.) that are part of that mentor's training program.
Although the mentors are affiliated with a variety of outside departments, they have served as mentors to postdoctoral fellows on our department's Women's Reproductive Health Research (WRHR) training grant since 1999.
Thus, these specific mentors have strong ties to our department and were selected from among many researchers in gynecologic cancers at both UW and FHCRC because of their previous experience successfully training clinical fellows in ob/gyn research.
Research mentors
The current list of research mentors, all of whom have joint appointments at both FHCRC and the UW, includes:
- Kemi Doll, MD, MSCD, Professor, Departments of Obstetric and Gynecology and Public Health (UW)
- Rosana Risques, PhD, Professor, Department of Laboratory Medicine & Pathology (UW)
- Mary (Nora) Disis, MD, Professor, Department of Medicine (UW/FHCC)
- David Flum, MD, MPH, Professor, Departments of Surgery and Public Health (UW)
- Denise Galloway, PhD, Professor, Microbiology (UW)
- Stephen Hawes, MS, PhD, Associate Professor, Epidemiology (UW)
- Mary-Claire King, PhD, Professor, Departments of Medicine & Genome Sciences (UW)
- Elizabeth Swisher, MD, Professor, Director, Gynecologic Oncology, Department of Obstetrics and Gynecology (UW)
Recent Fellow Thesis projects
- Ann Oluloro, MD, MPH (2025) – Association between comorbidity and clinical trial enrollment for patients with uterine cancer.
- Isabel Rodriguez, MD (2024) - Development and Validation of a Quantitative Assay to Identify and Characterize BRCA1 and RAD51C Methylated Ovarian Carcinoma
- Talayeh Ghezelayagh, MD, MPH (2023) - Evaluation of TP53 mutations in Pap test and blood DNA as novel biomarkers of ovarian cancer risk
- Leeya F. Pinder, MD (2022) - Single-dose HPV catch-up vaccination efficacy: A blinded, randomized study of single-dose HPV vaccination among adolescent girls and young women in Kenya
- Soledad Jorge, MD (2021) - Characterization of the Early Years of Bevacizumab Use for First Line Treatment of Ovarian Cancer in the United States
- Christopher Brooks Morse, MD (2020) - Development of a clinically relevant ovarian cancer model incorporating surgical cytoreduction to evaluate treatment of micrometastatic disease
- Emily Shuyi Wu, MD (2019) - The association between HIV infection and cervical cancer presentation and survival in Uganda
- Jovana Yanique Martin, MD (2018) - Preventive healthcare utilization among with endometrial cancer in the survivorship period
- Tiffany Lee Beck, MD (2017) - Robotic Assisted Surgery Compared with Laparoscopy and Laparotomy in the Treatment of Endometrial Cancer in Washington State, 2008-2011